VIENNA—Estrogen receptor negative breast cancer might be prevented by strategies under investigation including HER2-targeting, vaccination and treatment with metformin or retinoids. Powel Brown MD, Chairman of the Department of Clinical Cancer Prevention at the University of Texas MD Anderson Cancer Center in Houston, summarized the evidence for Oncology Times reporter Sarah.
You may also like...
International Research and Consensus Needed to Interpret Breast Cancer Genomics Data 27 Mar, 2015 When Good Cells Go Bad: The Stem Cell Origin of Cancers 16 Mar, 2007 Gastrointestinal Cancers: Progress with Targeted Therapies 27 Jan, 2008 Postoperative chest node irradiation extends life in low relapse-risk breast cancer 9 Oct, 2013
- Previous story Preventing ER-Positive Breast Cancer—Latest from IBIS 1, 2 and 3
- Next story Genetic Tests for Breast Cancer Late Recurrence Risk—Not Yet Ready for Prime Time
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014